MedPath

Optimal Dosage of Remifentanil for Vertebroplasty

Phase 4
Completed
Conditions
Remifentanil
Analgesia
Interventions
Drug: Initial remifentanil effect-site concentration
Registration Number
NCT05876039
Lead Sponsor
Tri-Service General Hospital
Brief Summary

Percutaneous vertebroplasty has become a mainstay in the management of osteoporotic and malignant vertebral fractures. Procedural analgesia and sedation (PAS) with propofol and remifentanil may provides optimal hypnotic and analgesic effects.

Detailed Description

Percutaneous vertebroplasty has become a mainstay in the management of osteoporotic and malignant vertebral fractures. Many anesthetic methods have been used in percutaneous vertebroplasty; however, there is no gold-standard method. Procedural analgesia and sedation (PAS) are one of the commonly used approaches. For its unique properties, including rapid onset, precise intraoperative control, and a fast recovery profile, remifentanil is preferable to other opioids administration in a target-controlled infusion (TCI) pump. Combination of remifentanil with propofol may improve sedation experience; however, it can increase a risk of respiratory depression. Moreover, propofol and remifentanil are often administered with 2 TCI pumps to, respectively, provide hypnotic and analgesic effects, which together are considered to be an ideal anesthetic technique.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
80
Inclusion Criteria
  • American Society of Anesthesiologists (ASA) score of I-III patients receiving percutaneous vertebroplasty under procedural sedation and analgesia with remifentanil and propofol
Read More
Exclusion Criteria
  • Age < 20 or > 80 years
  • ASA classifications > III
  • Pregnancy
  • Known allergies to opioids, propofol or any drugs used in the study
  • Emergency surgery
  • Patient refusal
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group remifentanil of 1.0 ng/mLInitial remifentanil effect-site concentrationInitial remifentanil effect-site concentration of 1.0 ng/mL
Group remifentanil 2.0 ng/mLInitial remifentanil effect-site concentrationInitial remifentanil effect-site concentration of 2.0 ng/mL
Primary Outcome Measures
NameTimeMethod
Adequate analgesia at the time of the trocar needle insertionTime at the trocar needle placement

Remaining moveless at the time of the trocar needle insertion

Adequate analgesia at the time of the bone cement injectionTime at the bone cement injection

Remaining moveless at the time of the bone cement injection

Secondary Outcome Measures
NameTimeMethod
Hypotension at the time of the trocar needle placementTime at the trocar needle placement

Mean blood pressure \> 30% decrease from baseline

Hypotension at the time of the bone cement injectionTime at the bone cement injection

Mean blood pressure \> 30% decrease from baseline

Apnea with desaturation at the time of the trocar needle placementTime at the trocar needle placement

Oxygen saturation \< 95%

Apnea with desaturation at the time of the bone cement injectionTime at the bone cement injection

Oxygen saturation \< 95%

TCI pump adjustments at the time of the trocar needle placementTime at the trocar needle placement

Frequency of TCI pump adjustments

TCI pump adjustments at the time of the bone cement injectionTime at the bone cement injection

Frequency of TCI pump adjustments

Numeric rating scalePostoperative one hour

Postoperative numeric rating scale. NRS scores is labeled from zero to ten, with zero being an example of someone with no pain and ten being the worst pain possible.

Trial Locations

Locations (1)

Tri-Service General Hospital

🇨🇳

Taipei, Taiwan

© Copyright 2025. All Rights Reserved by MedPath